Home » Epilepsy Blog » Partner » SKLifeScience » Make the most of your next doctor’s visit with the STEPS discussion tool

Make the most of your next doctor’s visit with the STEPS discussion tool

Seize the Truth about Epilepsy Perceptions

The “Seize the Truth About Epilepsy Perceptions” (STEP) Survey, was developed by SK Life Science, Inc. to understand the current state of epilepsy in the United States and to foster better communication between patients and their care teams. According to WebMD, results from the Seize the Truth About Epilepsy Perceptions (STEP) Survey revealed eye-opening insights showing that patients, doctors and caregivers aren’t having the right conversations in the doctor’s office, which may lead to miscommunication and incorrect perceptions.

STEPS Discussion Guide

Now you can take the survey yourself and use it as a discussion guide before your next neurologist, or epileptologist appointment. We’ve provided links to the survey in english and spanish. This is a wonderful tool to prepare for your next doctor’s visit.

author avatar
Jessica K. Smith Founder and CEO; Executive Director
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.